Senator Durbin seeks support for MPL legislation
December 8, 2022
Yesterday, U.S. Senate Majority Whip Dick Durbin (D-IL) delivered a speech on the Senate floor seeking support from his colleagues to include mandatory product listing (MPL) provisions from his Dietary Supplement Listing Act (DSLA) in the end-of-year omnibus appropriations bill.
The MPL provisions from the DSLA, which Durbin introduced with U.S. Senator Mike Braun (R-IN) in April, would amend the Food Drug and Cosmetic Act (FD&CA) to require marketers of dietary supplements sold in the United States to list their products with the U.S. Food and Drug Administration (FDA). Durbin's bid to include MPL provisions in the omnibus bill comes as the current continuing resolution funding the federal government is set to expire on December 16.
Last week, in a letter sent to the leadership of the Senate and House of Representatives committees with oversight over FDA, the American Herbal Products Association (AHPA) requested that Congress not include MPL language in any must-pass appropriations legislation considered during the last weeks of the 117th Congress. AHPA also suggested that any discussion of changes to federal laws regulating dietary supplements should occur as part of a transparent and stakeholder-inclusive process in the 118th Congress that will convene in January 2023.
AHPA will continue to advocate for commonsense reforms to dietary supplement laws, including greater consumer access to truthful information about dietary supplements and a more equitable and transparent path to market for new dietary ingredients.